11 April 2023 - Medicines Australia welcomes the official start of the Health Technology Assessment (HTA) Review consultation that should deliver bold reforms to how medicines are assessed, valued and made available in Australia.

CEO of Medicines Australia, Elizabeth de Somer, said that after 30 years it is long past time for reform to the HTA policies and methods to ensure Australians have timely access to the latest medicines and vaccines.

Read Medicines Australia press release